: Ranked as a "Best Buy" by Morningstar due to its "Wide Economic Moat" and dominance in the GLP-1 (weight loss/diabetes) sector.
For April 2026, analysts and market data highlight several top-performing and undervalued pharmaceutical stocks driven by strong pipelines in obesity, diabetes, and oncology.
: The top pick for those looking at Indian markets, cited as a long-term leader in specialty drugs. top pharma stocks to buy now
: Frequently cited as a top pick for its leadership in the weight-loss market with Mounjaro and Zepbound . It remains the world's largest healthcare company by market cap.
Table of Contents * The 12 Best Healthcare Stocks to Buy Now. * Coloplast. * Veeva Systems. * Philips. * Zoetis. * Novo Nordisk. * Morningstar : Ranked as a "Best Buy" by Morningstar
: A staple for value investors, focusing on its next-generation immunology drugs to offset the patent loss of its blockbuster drug Humira.
: Identified by Morningstar as one of the most undervalued wide-moat stocks, currently trading below its fair value. : Frequently cited as a top pick for
: Recognized for its strong clinical momentum in oncology and its leading HIV franchise, with consistent revenue growth reported recently. Global & High-Growth Tickers